Salus Group

What Salus Group does

Salus Group (legal entity SALUS, Ljubljana, d.d.) is a publicly traded Slovenian pharmaceutical commercialization and distribution group operating across 18 Central and Eastern European markets. Founded in 1969 and listed on the Ljubljana Stock Exchange in 1992 under ticker SALR, the company employs more than 700 experts and reported FY2025 consolidated revenue of €696 million. Its core offering is an integrated platform that represents multinational pharmaceutical, biotech, and MedTech principals in CEE markets, bundling market access, regulatory affairs, pharmacovigilance, medical affairs, marketing and sales, and physical distribution into a single outsourcing relationship.

The business is organized around three operational pillars: (1) Commercial Partnerships representing multinationals such as Pfizer, MSD/Merck, Biogen, Amicus Therapeutics, Organon, Recordati, Ferring, Angelini, Orphalan, Neuraxpharm, Abbott, Alcon, Zoetis, and Elanco across CEE; (2) Wholesale distribution through the SALUS Veletrgovina subsidiary and regional CARSO pharm entities in Slovenia, Montenegro, Bosnia and Herzegovina, Lithuania, and Albania, supplying pharmacies, hospitals, healthcare institutions, and veterinary practices; and (3) Retail through the wholly-owned Sanolabor chain of 40+ specialty stores plus the sanolabor.si online store, selling OTC products, medical devices, dietary supplements, orthopedic footwear, and consumer health products directly to Slovenian consumers. Supporting technology includes the eSalus Plus B2B ordering platform for partners, a 24-hour pharmacovigilance contact system, and dedicated infrastructure for NP/MRP/DCP/CP regulatory procedures.

Revenue is generated through wholesale transaction margins on pharmaceutical and medical device distribution, professional service fees for market access, regulatory affairs, pharmacovigilance, and medical affairs work, and retail markups on Sanolabor consumer products. The company has pursued a consistent inorganic growth strategy through acquisitions (Sanolabor in 2018, BENIFARM and MEDIFIT in 2020, MEDORION and MEDITRADE in 2023, FARMADENT in 2025) and regional entity establishment (CARSO pharm network), combined with selective portfolio rationalization (FARMEDICA divestiture in 2026). The group is governed by a two-tier Management Board and Supervisory Board structure with CEO Žiga Hieng (CFA) leading the Management Board, and operates as a public limited company with no controlling parent entity.

Name

Salus Group

Legal name

SALUS, Ljubljana, d.d.

Website

https://salus.eu

Company type

Public

Founded year

1969

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Salus Group is a publicly traded Slovenian pharmaceutical commercialization and distribution group that represents multinational pharmaceutical, biotech, and MedTech companies across 18 Central and Eastern European markets, bundling market access, regulatory affairs, pharmacovigilance, and distribution into integrated partnerships.

Ownership category

akta.pro rank

Headquarters

HQ city

Ljubljana

HQ country

Slovenia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Wholesale Distribution: Reliable, safe and efficient supply of pharmaceutical products, medical devices, sanitary materials, dietary supplements, cosmetics, pharmaceutical packaging, and other health products to pharmacies, hospitals, healthcare centers, veterinary institutions and other partners
2. Commercial Partnerships: Revenue from representing multinational pharmaceutical companies in CEE markets, including market access services, regulatory affairs, medical affairs, marketing and sales services
3. Retail Sales: Retail sales through Sanolabor specialized stores and online platform offering OTC products, medical devices, dietary supplements, orthopedic footwear, and healthy lifestyle products to end consumers
4. Market Access Services: Data-driven market entry services including optimal pricing positioning, efficient reimbursement inclusion, and timely sustainable patient access to innovative therapies
5. Regulatory and Pharmacovigilance Services: Comprehensive regulatory affairs services for human and veterinary medicines, medical devices, and food supplements, plus pharmacovigilance and medical device vigilance services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Salus Group is an integrated pharmaceutical commercialization and distribution partner for Central and Eastern Europe (CEE). It represents multinational pharmaceutical, biotech, and MedTech companies across 18 CEE markets, providing commercial partnerships, wholesale distribution, and value-added services including market access, regulatory affairs, pharmacovigilance, medical affairs, and marketing/sales. It also operates Sanolabor, the largest network of specialized pharmacy/medical device retail stores in Slovenia (40+ locations and online).

Product overview

Salus Group operates as an integrated pharmaceutical commercialization and distribution partner for Central and Eastern Europe. The company offers a unified platform of services comprising commercial partnerships (representing multinationals in CEE), wholesale distribution, and specialized retail through Sanolabor stores. Service modules include Market Access (pricing and reimbursement strategies), Regulatory Affairs and Pharmacovigilance, Marketing and Sales, Medical Affairs, and Distribution in CEE. The company serves four therapeutic portfolios: RX and Rare Diseases (neurology, endocrinology, cardiology, etc.), Consumer Healthcare (OTC products, supplements, medical devices), Medical Devices and Diagnostics (laboratory, renal, surgical, radiology equipment), and Animal Health (veterinary products). Key products include Pepaxti® (via Oncopeptides partnership) for multiple myeloma treatment.

Differentiator

Problem solved

Functional benefit

Brands

• Sanolabor: Largest network of specialized stores in Slovenia offering medical devices, OTC products, food supplements, orthopaedic footwear and healthy lifestyle products
• Salus Animal Health
• Salus+ Magazine
• Market Access Services

Products and services

• Commercial Partnerships Representation of multinational pharmaceutical, biotech, and MedTech companies in Central and Eastern European markets, providing integrated commercialization services including market access, regulatory affairs, medical affairs, marketing, and sales. Targeted at multinational pharmaceutical companies seeking CEE market entry.
• Pharmaceutical Wholesale Reliable, safe, and efficient supply of pharmaceutical products, medical devices, sanitary materials, dietary supplements, cosmetics, and pharmaceutical packaging to pharmacies, hospitals, healthcare centers, veterinary institutions, and other partners in Slovenia.
• Market Access Services Data-driven market entry services including optimal pricing positioning, efficient reimbursement inclusion, and timely sustainable patient access to innovative therapies across CEE markets. For pharmaceutical companies launching products in CEE.
• Regulatory Affairs and Pharmacovigilance Regulatory services for human and veterinary medicines, medical devices, and food supplements covering national procedures (NP), mutual recognition procedures (MRP), decentralized procedures (DCP), centralized procedures (CP), plus 24-hour pharmacovigilance, adverse event reporting, SOP preparation, and regulatory authority communication.
• Marketing and Sales Services Marketing communication and sales services including digital advertising in pharmacies, the Salus+ magazine (print and digital), telemarketing to pharmacies and specialized stores, and field sales team contact with channel partners.
• Medical Affairs Services Medical strategy development, scientific communication, key opinion leader (KOL) engagement, advisory board organization, and healthcare professional communication review for partner pharmaceutical companies.
• Distribution in CEE Pharmaceutical product distribution across 18 Central and Eastern European markets via established regional distribution hubs in Slovenia with long-standing partnerships with local distributors ensuring end-customer delivery.
• Sanolabor Retail
• Salus Animal Health Specialized division within Salus Wholesale dedicated to veterinary product distribution, supporting veterinary practices, clinics, hospitals, farms, and pet stores with companion animal and livestock health products from partners such as Zoetis and Elanco.
• Pepaxti (Multiple Myeloma Therapy)

Quantifiable outcome

• 20+ innovative medicines successfully included in reimbursement systems in CEE countries in the last two years
• +2 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

22 partnerships are on record, tiered core and minor.

• OncopeptidescoreStrategic or Co-development Partner · 27 May 2026Salus Group partnered with Oncopeptides to expand access to Pepaxti® (targeted therapy for multiple myeloma) across Central and Eastern Europe. This partnership enables patients in CEE who have exhausted existing treatment options to access this fully approved innovative therapy, addressing the gap between regulatory approval and actual patient access in the region.
• AlconcoreChannel Partner/ Reseller/ DistributorPartner for consumer healthcare products including OTC medicines and medical devices in CEE markets
• Amicus TherapeuticscoreChannel Partner/ Reseller/ DistributorPartner for rare disease therapies commercialization in CEE region
• Angelini PharmacoreChannel Partner/ Reseller/ DistributorCommercial partnership for pharmaceutical products in CEE markets
• BiogencoreChannel Partner/ Reseller/ DistributorPartner for neurological and specialty therapies in CEE region
• Ferring PharmaceuticalscoreChannel Partner/ Reseller/ DistributorPartner for specialty care products commercialization in CEE markets
• MSD (Merck)coreChannel Partner/ Reseller/ DistributorPartner for innovative medicines in CEE markets
• MerckcoreChannel Partner/ Reseller/ DistributorCommercial partnership for pharmaceutical products
• NeuraxpharmcoreChannel Partner/ Reseller/ DistributorPartner for CNS (central nervous system) therapies in CEE markets
• OrganoncoreChannel Partner/ Reseller/ DistributorPartner for women's health and other therapeutic areas
• OrphalancoreChannel Partner/ Reseller/ DistributorPartner for rare disease treatments in CEE markets
• PfizercoreChannel Partner/ Reseller/ DistributorCommercial partnership for innovative medicines in CEE region
• RecordaticoreChannel Partner/ Reseller/ DistributorLong-standing partnership for pharmaceutical products in CEE
• AbbottcoreChannel Partner/ Reseller/ DistributorPartner for medical devices and diagnostics in CEE markets
• ZoetiscoreChannel Partner/ Reseller/ DistributorPartner for animal health products distribution in Slovenia
• ElancocoreChannel Partner/ Reseller/ DistributorPartner for animal health products in Slovenian market
• JamiesonminorChannel Partner/ Reseller/ DistributorPartner for consumer healthcare (dietary supplements) products
• ReckittminorChannel Partner/ Reseller/ DistributorPartner for consumer healthcare products
• VantiveminorChannel Partner/ Reseller/ DistributorPartner for renal care medical devices
• BaxterminorChannel Partner/ Reseller/ DistributorPartner for medical devices including dialysis solutions
• Karl StorzminorChannel Partner/ Reseller/ DistributorPartner for surgical and endoscopic instruments
• Health Insurance Institute of SloveniacoreStrategic or Co-development PartnerSanolabor is a contractual partner of the Health Insurance Institute of Slovenia (ZZZS), ensuring that high-quality medical and orthopedic devices prescribed by physicians are available to insured persons in Sanolabor stores, either on permanent ownership or rental basis

Scale indicators6 records

Recent moves16 records

Expansion highlights6 records

Regional players

• Sopharma Trading: Sopharma Trading is a leading Bulgarian pharmaceutical distributor and part of the Sopharma Group, serving pharmacies, hospitals, and healthcare institutions primarily in Bulgaria and the Balkans. Comparable to Salus as a CEE regional pharma wholesaler with similar customer mix and product categories.
• Zentiva: Zentiva is a European generics pharmaceutical company headquartered in Prague with strong CEE roots and operations across multiple European markets. Comparable to Salus in CEE pharmaceutical market coverage and pharmacy/hospital distribution, though with a generics manufacturing core.
• Hemofarm (STADA Group): Hemofarm is a leading Serbian pharmaceutical manufacturer and distributor, part of the STADA Group, with strong presence across the Western Balkans and CEE. Comparable to Salus in CEE pharma distribution, though Hemofarm's primary orientation is manufacturing rather than third-party commercialization.
• Richter Gedeon: Richter Gedeon is a major Hungarian pharmaceutical company with significant CEE, CIS, and Western European presence, active in branded generics, specialty, and women's health. Comparable to Salus in CEE pharmaceutical market access and commercial reach, though anchored in proprietary products.
• Egis Pharmaceuticals: Egis Pharmaceuticals is a Hungarian-based pharmaceutical company with manufacturing and distribution across CEE and CIS markets. Comparable to Salus in CEE pharmaceutical distribution and market access, though vertically integrated into manufacturing rather than a pure commercialization partner.

Direct peers

• McKesson Europe (formerly Celesio/Lloyds Pharmacy): McKesson Europe operates pharmaceutical wholesale and retail pharmacy businesses across continental Europe, including CEE markets. Overlaps with Salus on wholesale distribution and pharma services, though with a broader and more mature European footprint.
• PHOENIX Group: PHOENIX Group is the largest pharmaceutical wholesaler in Europe, operating across more than 27 countries with integrated pharmacy retail and pharma services. Directly comparable to Salus as a pan-European pharma distribution and services platform, though at materially larger scale.
• Alliance Healthcare (Walgreens Boots Alliance): Alliance Healthcare is the European pharmaceutical wholesale and distribution arm of Walgreens Boots Alliance, operating across multiple European markets including Central and Eastern Europe. Comparable to Salus in wholesale, distribution, and value-added services for pharma manufacturers.

Broad incumbents

• Mediq: Mediq is a European healthcare services and medical device distribution company operating across multiple countries. Comparable to Salus in medical device distribution and broader healthcare product distribution, though Mediq focuses more on direct-to-patient and provider channels.
• Cencora (formerly AmerisourceBergen): Cencora is one of the largest global pharmaceutical distribution and services companies, providing wholesale, specialty distribution, and commercialization services. Comparable to Salus in the integrated pharma commercialization model, though operating at massive global scale rather than regionally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/salus-group-skupina-salus

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salus Group